Epithelial ovarian carcinoma is often diagnosed at an advanced stage of dis
ease and is the leading cause of death from gynaecological neoplasia. The g
enetic changes that occur during the development of this carcinoma are poor
ly understood. It has been proposed that IGFIIR, TGF beta1 and TGF beta RII
act as a functional unit in the TGF beta growth inhibitory pathway, and th
at somatic loss-of-function mutations in any one of these genes could lead
to disruption of the pathway and subsequent loss of cell cycle control. We
have examined these 3 genes in 25 epithelial ovarian carcinomas using singl
e-stranded conformational polymorphism analysis and DNA sequence analysis.
A total of 3 somatic missense mutations were found in the TGF beta RII gene
, but none in IGFRII or TGF beta1. An association was found between TGF bet
a RII mutations and histology, with 2 out of 3 clear cell carcinomas having
TGF beta RII mutations. This data supports other evidence from mutational
analysis of the PTEN and beta -catenin genes that there are distinct develo
pmental pathways responsible for the progression of different epithelial ov
arian cancer histologic subtypes. (C) 2001 Cancer Research Campaign.